05 - 06 December, 2018
Grand Copthorne Waterfront Hotel, Singapore

Conference Day Two – Thursday, 6th Dec 2018

8:00 am - 8:50 am Morning Refreshment and Registration

8:50 am - 9:00 am Opening Remarks from the Chairperson

9:00 am - 9:40 am Novo Nordisk Case Study: Achieving High Patient Recruitment And Retention Rate by Cost-Effective Site Operation

Shweta Uppal - Head- Clinical, Medical, Regulatory, Quality and Pharmacovigilance, Novo Nordisk
-Selecting the Great site based on Feasibility Check, Protocol Infrastructure etc
-Building sustainable ecosystem with local community to engage patients/patients’ family/PI
-Leveraging on clinical trials operation for designing medical affairs strategy
img

Shweta Uppal

Head- Clinical, Medical, Regulatory, Quality and Pharmacovigilance
Novo Nordisk

9:40 am - 10:20 am Case Study: Transforming Your Clinical Trial Operation By Implementing Artificial Intelligence

Emily Tan - Corporate Vice President, Portfolio Leadership, PAREXEL
-Using AI to analyse all the compounds and compare it with clinical data
-Saving one quarter of time and one quarter of cost by utilizing AI during operation
-Up-skilling your talents to work hand-in-hand with AI applications
img

Emily Tan

Corporate Vice President, Portfolio Leadership
PAREXEL

10:20 am - 11:05 am Panel Discussion: Decentralised Clinical Trials – Providing an Opportunity to Enable Radical Transformation in Clinical Trial Methodology

Kunal Shah - Senior Manager Clinical Operations, Eisai
-Whether decentralized clinical trials suitable for every case, if so, what can you prepare for the future implementation, if not, what is the next-generation clinical trials operation looks like?
-How decentralized clinical studies enhance patient centricity?
-Legal, regulatory and practical consideration to achieve decentralized clinical trials
-Implementing decentralized clinical trials into real world evidence collecting
img

Kunal Shah

Senior Manager Clinical Operations
Eisai

11:05 am - 11:20 am Speed Networking

11:20 am - 11:50 am Networking Break

Topical Roundtables

Machine Learning

11:50 am - 1:10 pm How To Train Machines To Think Like Physicians

Machine Learning

11:50 am - 1:10 pm Obstacles And Solutions For Machine Learning Implementation

Machine Learning

11:50 am - 1:10 pm Upskilling Your Team For Value-Added Work

Artificial Intelligence

11:50 am - 1:10 pm Overcoming challenges during AI Implementation

Artificial Intelligence

11:50 am - 1:10 pm Partnering Strategy For AI Solutions (Vendors)

Artificial Intelligence

11:50 am - 1:10 pm How To Get Higher ROI For AI Implementation?

2:10 pm - 2:50 pm Understanding the Opportunity to Achieve Next-Generation Clinical Trials in Indonesia

Rizman Abudaeri - Director, Market Access, Government Affair and Regulatory Affair, PT AstraZeneca Indonesia
-Sharing Indonesia’s current state and future expectations in terms of clinical trials
-Discussing the potential opportunity for technology implementation based on large scale of population and booming mobile internet applications
-Analysing the risks and potential ROI brought about by technology implementation in Indonesia
img

Rizman Abudaeri

Director, Market Access, Government Affair and Regulatory Affair
PT AstraZeneca Indonesia

2:50 pm - 3:30 pm Case Study: Achieving Operational Excellence by Continuously Reviewing Your Clinical Trial Performance

Hemant Singh Bhadauria - Associate Director- Oncology, Medical Affairs Asia Oceania, Astellas Pharma
-Benchmarking your clinical trial operation with industry leaders and embarking on continuous improvement
-Understanding how does technology helps  achieve operational excellence
-Upskilling your people to build a solid culture of continuous improvement within clinical trials
img

Hemant Singh Bhadauria

Associate Director- Oncology, Medical Affairs Asia Oceania
Astellas Pharma

3:30 pm - 4:10 pm Case Study: Leveraging Post Marketing Evidence To Get Greater Insights by Data Analytics

Hemant Singh Bhadauria - Associate Director- Oncology, Medical Affairs Asia Oceania, Astellas Pharma
-Outlining the value of pre-engagement and direct involvement of patients, sites, health authorities and ethics committee during the development of smart technologies
-Discussing the power of cross-industry collaborations with technical, mobile and package vendors, and open communications
-Ensuring the right pill to the right patient at the right time – implementing smart technologies (e.g. smart packages, digital drug labels, tailored notifications, scanning devices) in a phase II clinical trial with Alzheimer patients
img

Hemant Singh Bhadauria

Associate Director- Oncology, Medical Affairs Asia Oceania
Astellas Pharma

4:10 pm - 4:40 pm Networking Break

4:40 pm - 5:20 pm Case Study: Implementing AI And Data Analytics Tools To Achieve Efficient Biomarker Identification

-Collecting and analysing patients’ data to get understandable interpretation
-Partnering with solution-provider closely for better solution  to achieve higher ROI
-More efficiently Identify biomarker, quicker clinical trial operation
-Extracting biomarker information using Natural Language Understanding

5:20 pm - 6:05 pm Panel Discussion: Achieving Innovative Clinical Trial Operations In APAC Through Strategic Partnership

Emily Tan - Corporate Vice President, Portfolio Leadership, PAREXEL
Yow Wei Ter - Site Relationship and Operations Lead, Merck Serono
-Understanding the obstacles for technology implementation during clinical trial and Solve it through partnership
-Analysing the suitable solutions for the APAC market
-Discussing the evolving partnership model between regulator, CROs, technology solution provider, hospitals and pharma companies
img

Emily Tan

Corporate Vice President, Portfolio Leadership
PAREXEL

Yow Wei Ter

Site Relationship and Operations Lead
Merck Serono

6:05 pm - 6:10 pm Closing Remarks from Chairperson & Close of Conference Day Two